Back to overview
With Senior Management from both our German headquarters and US subsidiary joining, we are looking forward to starting off the new year 2024 with an inspirational week of meetings and the opportunity to connect to stakeholders of the biotech industry. If you are interested in discussing novel antiviral therapy options for patients with a weakened immune system, as well as exciting business opportunities, ask for a meeting via info@aicuris.com.